NEW YORK, Sept. 10, 2023 /PRNewswire/ — The autoclave market is expected to grow by USD 571.78 million from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 6.14% during the forecast period, according to Technavio Research. The market has been segmented by type (vertical autoclaves, horizontal autoclaves, and others), end-user (healthcare facilities and diagnostic laboratories, pharmaceutical, biotechnology, medical device companies, and academic and research institutes), and geography (North America, Europe, Asia, and Rest of World (ROW)). North America is estimated to contribute 34% to the growth of the global market during the forecast period. The growing number of surgical procedures, coupled with the increasing incidence of chronic diseases, the presence of pharmaceutical and biopharmaceutical companies, and the increasing investment in research activities public and private research and development (R&D), as the main drivers of growth. of the autoclave market in North America. In addition, increasing healthcare costs and the presence of prominent providers are driving market growth in the region. The prevalence of chronic and lifestyle-related diseases has increased across North America. Heart disease is one of the most diagnosed diseases of all ages in North America. Hence, these factors are expected to drive market growth in the region during the forecast period. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read PDF Sample Report
Company Profile:
ANTONIO MATACHANA SA, Azbil Corp., Celitron Medical Technologies Kft., De Lama Spa, Fedegari Autoclavi Spa, Getinge AB, Johnson and Johnson Services Inc., LTE Scientific Ltd., MELAG Medizintechnik GmbH and Co. KG, Metall Zug AG, PHC Holdings Corp., Rodwell Engineering Group Ltd., Sakura Global Holding Co. Ltd., STERIS Corp., Tuttnauer Israel Ltd., Yamato Scientific Co. Ltd., ZIRBUS technology GmbH, Astell Scientific, Benchmark Scientific Inc., and Stahlbau engineering gmbh
ANTONIO MATACHANA SA – The company offers autoclave products such as medical autoclave S2000.
To gain access to more company profiles available with Technavio, buy the report!
Autoclave Market: Segmentation Analysis
- The market share growth by the vertical autoclaves segment will be significant during the forecast period. They provide solutions for hospitals and clinics where reliable sterilization is critical. Other advantages of vertical autoclaves include greater portability and ease of use, making them very popular and practical.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report
“Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021”- Technavio
Autoclave Market: Drivers:
- Increasing need for waste management in healthcare facilities
- Increasing surgical procedures coupled with the sterilization of medical devices
- Growing demand for autoclave equipment to prevent HAIs
The increasing need for waste management in healthcare facilities is a key factor driving market growth. Hospital waste is generated as a by-product of various diagnostic and therapeutic procedures performed in healthcare facilities. These may include radioactive waste, infectious waste, hazardous waste, or common hospital waste. Medical waste disposal methods are used by healthcare providers to deal with the huge amount of biohazardous waste generated. Autoclaving, chemical sterilization, and packaging are the main solutions used by healthcare providers prior to medical waste disposal. The autoclave is mainly used as a heat treatment device to kill microorganisms before the waste is further treated or destroyed in a conventional landfill. Providers such as Celitron Medical Technologies Kft. (Celitron Medical Technologies) and Tuttnauer offers a wide range of autoclaves for the treatment of medical waste generated by healthcare facilities by sterilization. Hence, these factors are expected to drive market growth during the forecast period.
Identify key trends, drivers, and challenges in the market. Download to gain access to this information.
Related Reports:
The companion diagnostics market is estimated to grow at a CAGR of 22.59% between 2022 and 2027. The market size is forecast to increase by USD 11,029.63 million. Furthermore, this report extensively covers market segmentation by end-user (life science, health centers, and others), indication (oncology, neurology, and others), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The rising use of personalized medicine is a key factor driving market growth during the forecast period.
The cancer diagnostics market is estimated to grow at a CAGR of 11.3% between 2022 and 2027. The market size is forecast to increase by USD 12,626.21 million. Furthermore, this report extensively covers market segmentation by end-user (hospitals and clinics, and diagnostic laboratories), type (IVD, imaging, and IDT), and geography (North America, Europe, APAC, and the Rest of the World (ROW)). The high prevalence of cancer is a key factor driving market growth during the forecast period.
What are the key data covered in this autoclave market report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the autoclave market between 2022 and 2027.
- Precise estimation of the autoclave market size and its contribution to the market in focus on the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the market across North America, Europe, Asia, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the growth of autoclave market companies.
ToC:
Executive Summary
Market Landscape
Market Sizing
Historic Market Sizes
Five Forces Analysis
Market Segmentation by End-User
Market Segmentation by Type
Market Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
